ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Revlon Foundation Gives $7.5 Million To UCA for Women’s Health Research, Breast Cancer

December 16, 1994

FDA Needs Staff, Funds But first Must Determine Priorities, GAO Says

November 17, 1989

Orphan Designation Granted To Advaxis HPV Immunotherapy

May 30, 2014

In Brief: Bleyer To Chair Childrens Cancer Study Group; Fisher To Advise; Penn. Awards Herberman

May 3, 1991

NCI Names 15 to Director’s Consumer Liaison Group.

January 14, 2005

Funding Opportunities.

April 11, 2003